Fate of cerebrospinal fluid-borne amyloid β-peptide: Rapid clearance into blood and appreciable accumulation by cerebral arteries

Journal of Neurochemistry

Volumn 67, Issue 2, 1996, Pages 880-883

  Ghersi Egea, J F ^a   Gorevic, P D ^a   Ghiso, J ^b   Frangione, B ^b   Patlak, C S ^a   Fenstermacher, J D ^a,c  

^a STONY BROOK UNIVERSITY   (United States)

^b NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c HENRY FORD HOSPITAL   (United States)

Author keywords

Alzheimer's disease; Amyloid peptide; Blood brain barrier; Cerebrovascular amyloidosis; Choroid plexus; CSF

Indexed keywords

AMYLOID; AMYLOID BETA PROTEIN; CARBON 14; IODINE 125; MACROGOL 4000; SYNTHETIC PEPTIDE;

ALZHEIMER DISEASE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BIOACCUMULATION; BLOOD; BRAIN ARTERY; CEREBROSPINAL FLUID; CLEARANCE; MALE; NONHUMAN; PRIORITY JOURNAL; RAT;

ANIMALIA;

EID: 0030035294     PISSN: 00223042     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1471-4159.1996.67020880.x     Document Type: Article

References (28)

1. Bereczki D., Wei L., Acuff V., Gruber K., Tajima A., Patlak C., and Fenstermacher J. (1992) Technique-dependent variations in cerebral microvessel blood volumes and hematocrits in the rat. Appl. Physiol. 73, 918-924.
2. Blasberg R., Patlak C., and Fenstermacher J. (1975) Intrathecal chemotherapy: brain tissue profiles after ventriculocisternal perfusion. J. Pharmacol. Exp. Ther. 195, 73-83.
3. Citron M., Vigo-Pelfrey C., Teplow D. B., Miller C., Schenk D., Johnston J., Winblad B., Venizelos N., Lannfelt L., and Selkoe D. J. (1994) Excessive production of amyloid β-protein by peripheral cells of symptomatic and presymptomatic patients carrying the Swedish familial Alzheimer disease mutation. Proc. Natl. Acad. Sci. USA 91, 11993-11997.
4. Eriksson L. and Westermark P. (1986) Intracellular neurofibrillary tangle-like aggregations: a constantly present amyloid alteration in the aging choroid plexus. Am. J. Pathol. 125, 124-129.
5. Fenstermacher J. and Davson H. (1982) Distribution of two model amino acids from cerebrospinal fluid to brain and blood. Am. J. Physiol. 242, F171-F180.
6. Games D., Adams C., Alessandrini R., Barbour R., Berthelette P., Blackwell C., Carr T., Clemens J., Donaldson T., Gillespie F., Guido T., Hagopian S., Johnson-Wood K., Kahn K., Lee M., Leibowitz P., Leiberburg I., Little S., Masliah E., McConlogue L., Montaya-Zavala M., Mucke L., Paganini L., Penniman E., Power M., Schenk D., Seubert P., Snyder B., Soriano F., Tan H., Vitale J., Wadsworth S., Wolozin B., and Zhao J. (1995) Alzheimer-type neuropathology in transgenic mice overexpressing V717F β-amyloid precursor protein. Nature 373, 523-527.
7. Ghersi-Egea J.-F., Finnegan W., Chen J.-L., and Fenstermacher J. D. (1996) Rapid distribution of intraventricularly administered sucrose into cerebrospinal fluid cisterns via subarachnoid velae in rat. Neuroscience (in press).
8. Ghiso J., Matsubara E., Koudinov A., Choi-Miura N. H., Tomita M., Wisniewski T., and Frangione B. (1993) The cerebrospinal-fluid soluble form of Alzheimer's amyloid beta is complexed to SP-40,40 (apolipoprotein J), an inhibitor of the complement membrane-attack complex. Biochem. J. 293, 27-30.
9. Ikeda S.-I., Allsop D., and Glenner G. G. (1989) Morphology and distribution of plaque and related deposits in the brains of Alzheimer's disease and control cases. Lab. Invest. 60, 113-122.
10. Iwatsubo T., Mann D. M. A., Odaka A., Suzuki N., and Ihara Y. (1995) Amyloid β-protein (Aβ) deposition: Aβ42 (43) precedes Aβ40 in Downs syndrome. Ann. Neurol. 37, 294-299.
11. Johnstone E. M., Chancy M. O., Norris F. H., Pascual R., and Little S. P. (1991) Conservation of the sequence of the Alzheimer's disease amyloid peptide in dog, polar bear, and five other mammals by cross-species polymerase chain reaction analysis. Mol. Brain Res. 10, 299-305.
12. Koudinov A., Matsubara E., Frangione B., and Ghiso J. (1994) The soluble form of Alzheimer's amyloid beta protein is complexed to high density lipoprotein 3 and very high density lipoprotein in normal human serum. Biochem. Biophys. Res. Commun. 205, 1164-1171.
13. Matsubara E., Frangione B., and Ghiso J. (1995) Characterization of apolipoprotein J-Alzheimer's Aβ interaction. J. Biol. Chem. 270, 7563-7567.
14. Miller D. L., Papayannopoulos I. D., Styles J., Bobin S. A., Lin Y. Y., Bieman K., and Iqbal K. (1993) Peptide composition of the cerebrovascular and senile plaque core amyloid deposits of Alzheimer's disease. Arch. Biochem. Biophys. 301, 41-52.
15. Mitro A. and Palkovits M. (1981) Morphology of the rat brain ventricles, ependyma, and periventricular structures. Bibl. Anat. 21, 1-110.
16. Patlak C. and Fenstermacher J. (1975) Measurements of dog bloodbrain transfer constants by ventriculocisternal perfusion. Am. J. Physiol. 229, 877-884.
17. Rennels M., Gregory T., Blaumanis O., Fujimoto K., and Grady P. (1985) Evidence for a 'paravascular' fluid circulation in the mammalian central nervous system, provided by the rapid distribution of tracer protein throughout the brain from the subarachnoid space. Brain Res. 326, 47-63.
18. Seubert P., Vigo-Pelfrey C., Esch F., Lee M., Dovey H., Davis D., Sinha S., Schlossmacher M., Whaley J., Swindlehurst C, McCormack R., Wolfert R., Selkoe D., Lieberburg I., and Schenk D. (1992) Isolation and quantification of soluble Alzheimer's β-peptide from biological fluids. Nature 359, 325-327.
19. Shoji M., Golde T., Ghiso J., Cheung T., Estus S., Shaffer L., Cai X., McKay D., Tinter R., Frangione B., and Younkin S. (1992) Production of the Alzheimer amyloid β protein by normal proteolytic processing. Science 258, 126-129.
20. Shivers B. D., Hilbich C., Multhaup G., Salbaum M., Beyreuther K., and Seeburg P. H. (1988) Alzheimer's disease amyloidogenic glycoprotein: expression pattern in rat brain suggests a role in cell contact. EMBO J. 7, 1365-1370.
21. Soto C., Castano E., Kumar R., Beavis R., and Frangione B. (1995) Fibrillogenesis of synthetic amyloid β-peptides is dependent on initial secondary structure. Neurosci. Lett. 200, 105-108.
22. 717) mutants. Science 264, 1336-1340.
23. Tabaton M., Nunzi M. G., Xue R., Usiak M., Autilio-Gambetti L., and Gambetti P. (1994) Soluble amyloid β-protein is a marker of Alzheimer amyloid in brain but not in cerebrospinal fluid. Biochem. Biophys. Res. Commun. 200, 1592-1603.
24. Vigo-Pelfrey C., Lee D., Keim P., Lieberburg I., and Schenk D. B. (1993) Characterization of β-amyloid peptide from human cerebrospinal fluid. J. Neurochem. 61, 1965-1968.
25. Vinters H. V. (1987) Cerebral amyloid angiopathy: a critical review. Stroke 18, 311-324.
26. Yamaguchi H., Hirai S., Morimatsu M., Shoji M., and Nakazato Y. (1989) Diffuse type of senile plaques in cerebellum of Alzheimers-type dementia demonstrated by β protein immunostain. Acta Neuropathol. (Berl.) 77, 314-319.
27. Zhang E. T., Inman C. B. E., and Weller R. O. (1990) Interrelationships of the pia mater and the perivascular (Virchow-Robin) spaces in the human cerebrum. J. Anat. 170, 111-123.
28. Zlokovic B. V., Marten C. L., Mackic J. B., Matsubara E., Wisniewski T., McComb J. G., Frangione B., and Ghiso J. (1994) Brain uptake of circulating apolipoprotein J and E complexed to Alzheimer's amyloid β. Biochem. Biophys. Res. Commun. 205, 1431-1437.